How have FHTX and NRXP total returns compared?

Over the past 5 years, FHTX delivered -31.87% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.

Foghorn Therapeutics Inc. (FHTX) vs NRx Pharmaceuticals, Inc. (NRXP)

A side-by-side comparison of Foghorn Therapeutics Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

FHTX

Foghorn Therapeutics Inc.

$116M

$1.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NRXP

NRx Pharmaceuticals, Inc.

$127M

$2.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — FHTX vs NRXP

growth of $100 · dividends reinvested · last 6y

FHTX -89.0% (-30.7%/yr)NRXP -97.3% (-45.4%/yr)FHTX compounded faster over this window

FHTX NRXP

FHTX vs NRXP: by the numbers

•NRXP is the larger company ($127M vs $116M market cap).
•Both run net losses; FHTX's is the smaller (-175.78% vs -691.81% net margin).

Metrics side by side

Valuation

Metric	FHTX	NRXP
P/S ratio	3.15	37.50

Profitability

Metric	FHTX	NRXP
Gross margin	89.22%	58.78%
Operating margin	-265.64%	-1324.41%
Net margin	-175.78%	-691.81%
ROIC	-44.81%	N/A

Growth (annualized)

Metric	FHTX	NRXP
Revenue CAGR (5Y)	105.83%	N/A
Total return CAGR (5Y)	-31.87%	-49.61%

Frequently asked

How have FHTX and NRXP total returns compared?: Over the past 5 years, FHTX delivered -31.87% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FHTX analysis Full NRXP analysis Interactive comparison tool

Dig into the metrics

Foghorn Therapeutics ROE NRx Pharmaceuticals ROE Foghorn Therapeutics operating margin NRx Pharmaceuticals operating margin Foghorn Therapeutics revenue growth NRx Pharmaceuticals revenue growth Foghorn Therapeutics free cash flow NRx Pharmaceuticals free cash flow

Foghorn Therapeutics & NRx Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.